A 52-year-old Caucasian farmer presents with a 3-year history of migratory polyarthralgia, followed by 18 months of chronic diarrhea, weight loss, and steatorrhea. Duodenal biopsy reveals blunted villi, dilated lacteals, and foamy macrophages in the lamina propria that are PAS-positive and diastase-resistant. PCR confirms Tropheryma whipplei. CSF examination shows no evidence of CNS involvement. The treatment regimen marked **A** in the diagram is initiated. Which of the following best describes why this regimen is the recommended first-line therapy for Whipple disease?
A. It provides rapid resolution of malabsorption through mucosal healing without requiring prolonged maintenance therapy beyond 4 weeks
B. It provides rapid bactericidal activity with excellent CNS penetration during induction, followed by prolonged oral suppression to prevent relapse and eradicate intracellular organisms
C. It achieves high intracellular concentrations in macrophages without requiring CNS penetration, as neurologic involvement is rare in Whipple disease
D. It targets the gram-negative aerobic component of the polymicrobial infection and prevents secondary fungal superinfection
Explanation
Why option 1 is correct
The regimen marked A (IV ceftriaxone 2 weeks followed by oral TMP-SMX for 12 months) is the gold-standard treatment for Whipple disease because it combines two critical principles: (1) the induction phase with IV ceftriaxone (or penicillin G + streptomycin) for 2–4 weeks achieves excellent CNS penetration and rapid bactericidal activity against the intracellular gram-positive actinomycete Tropheryma whipplei; (2) the maintenance phase with oral TMP-SMX for 12 months provides prolonged suppression and intracellular penetration to eradicate residual organisms and prevent the common relapses that occur with shorter courses. This dual-phase approach is essential because untreated Whipple disease has ~100% mortality, and even with adequate therapy, relapses are frequent without prolonged maintenance. Every patient requires CSF examination to exclude occult CNS disease, which mandates CNS-penetrating therapy.
Why each distractor is wrong
Option 2: Tropheryma whipplei is a gram-positive actinomycete, not gram-negative. The infection is monomicrobial, not polymicrobial. Fungal superinfection is not a recognized complication of Whipple disease, and this is not the rationale for the regimen.
Option 3: While intracellular penetration is important, CNS penetration is mandatory because occult CNS involvement occurs in ~15% of symptomatic cases and can be detected only by CSF PCR/PAS examination. The regimen is specifically designed to achieve CNS penetration during induction, and every patient must be screened for CNS disease regardless of symptoms.
Option 4: Whipple disease is a chronic multisystem infectious disease caused by an intracellular pathogen, not a mucosal inflammatory condition. Malabsorption resolves only after eradication of the organism, which requires prolonged therapy. Short-course therapy (4 weeks alone) results in high relapse rates and is inadequate.
High-YieldNEET PG
Whipple disease requires dual-phase therapy — IV cephalosporin/penicillin for 2–4 weeks (CNS penetration) followed by oral TMP-SMX for 12 months (intracellular eradication and relapse prevention); every patient needs CSF examination to detect occult CNS disease.
Marth T. Curr Opin Gastroenterol 2016; Harrison's Principles of Internal Medicine, 21st ed
Practice similar questions
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.
